| (R)-noradrenaline | increases expression | ISO | RGD:70491 | 6480464 | Norepinephrine results in increased expression of TGFB2 protein; more ... | CTD | PMID:15326086 |
| (R)-noradrenaline | multiple interactions | ISO | RGD:70491 | 6480464 | Prazosin inhibits the reaction [Norepinephrine results in increased expression of TGFB2 mRNA] | CTD | PMID:15326086 |
| 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane | multiple interactions | ISO | RGD:70491 | 6480464 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [FSHB protein affects the expression of TGFB2 mRNA] | CTD | PMID:19414516 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:730953 | 6480464 | Ethinyl Estradiol affects the expression of TGFB2 mRNA | CTD | PMID:20170705 |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:730953 | 6480464 | Ethinyl Estradiol results in decreased expression of TGFB2 mRNA | CTD | PMID:18936297 |
| 17beta-estradiol | affects expression | ISO | RGD:730953 | 6480464 | Estradiol affects the expression of TGFB2 mRNA | CTD | PMID:14699072 |
| 17beta-estradiol | multiple interactions | ISO | RGD:730953 | 6480464 | [Estradiol binds to ESR2 protein] which results in decreased expression of TGFB2 mRNA | CTD | PMID:20404318 |
| 17beta-estradiol | multiple interactions | ISO | RGD:730953 | 6480464 | [Raloxifene co-treated with Estradiol] results in increased expression of TGFB2 mRNA | CTD | PMID:21185374 |
| 17beta-estradiol | increases expression | ISO | RGD:730953 | 6480464 | Estradiol results in increased expression of TGFB2 mRNA | CTD | PMID:11813992 |
| 17beta-estradiol | decreases expression | ISO | RGD:730953 | 6480464 | Estradiol results in decreased expression of TGFB2 mRNA | CTD | PMID:16474171 more ... |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | Tetrahydrocannabinol promotes the reaction [Estradiol results in increased expression of TGFB2 mRNA] | CTD | PMID:8390853 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of TGFB2 mRNA | CTD | PMID:8390853 |
| 17beta-estradiol | decreases expression | ISO | RGD:730953 | 6480464 | Estradiol results in decreased expression of TGFB2 mRNA | CTD | PMID:16474171 PMID:19619570 |
| 17beta-estradiol | decreases expression | ISO | RGD:70491 | 6480464 | Estradiol results in decreased expression of TGFB2 mRNA | CTD | PMID:20068009 |
| 17beta-estradiol | multiple interactions | ISO | RGD:730953 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of TGFB2 mRNA | CTD | PMID:19619570 |
| 17beta-estradiol | multiple interactions | ISO | RGD:730953 | 6480464 | [Progesterone co-treated with Estradiol] results in decreased expression of TGFB2 mRNA | CTD | PMID:17404688 |
| 17beta-estradiol | affects expression | EXP | | 6480464 | Estradiol affects the expression of TGFB2 mRNA | CTD | PMID:15598610 |
| 17beta-estradiol | decreases expression | ISO | RGD:730953 | 6480464 | Estradiol results in decreased expression of TGFB2 mRNA | CTD | PMID:19619570 PMID:16474171 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:730953 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of TGFB2 mRNA | CTD | PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:730953 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TGFB2 protein | CTD | PMID:9787404 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | AHR protein promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of TGFB2 mRNA] | CTD | PMID:15034205 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:730953 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of TGFB2 mRNA | CTD | PMID:1447203 PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases chemical synthesis | ISO | RGD:730953 | 6480464 | Tetrachlorodibenzodioxin results in decreased chemical synthesis of TGFB2 mRNA | CTD | PMID:1447203 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of TGFB2 protein | CTD | PMID:17056225 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of TGFB2 mRNA | CTD | PMID:21131560 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of TGFB2 mRNA | CTD | PMID:19933214 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of TGFB2 mRNA | CTD | PMID:21131560 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of TGFB2 mRNA | CTD | PMID:21097750 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of TGFB2 mRNA | CTD | PMID:19933214 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TGFB2 mRNA | CTD | PMID:14728982 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of TGFB2 mRNA | CTD | PMID:21097750 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:730953 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of TGFB2 mRNA | CTD | PMID:19619570 |
| 2-nitrotoluene | decreases expression | ISO | RGD:70491 | 6480464 | 2-nitrotoluene results in decreased expression of TGFB2 mRNA | CTD | PMID:16460773 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:730953 | 6480464 | [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of TGFB2 mRNA | CTD | PMID:16997883 |
| 5-fluorouracil | affects response to substance | ISO | RGD:730953 | 6480464 | TGFB2 protein affects the susceptibility to Fluorouracil | CTD | PMID:16217747 |
| 5-fluorouracil | decreases response to substance | EXP | | 6480464 | TGFB2 gene polymorphism results in decreased susceptibility to Fluorouracil | CTD | PMID:18941179 |
| 8-bromo-3',5'-cyclic AMP | multiple interactions | ISO | RGD:730953 | 6480464 | [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of TGFB2 mRNA | CTD | PMID:16997883 |
| acetaldehyde | affects expression | EXP | | 6480464 | Acetaldehyde affects the expression of TGFB2 mRNA | CTD | PMID:22634333 |
| actinomycin D | multiple interactions | ISO | RGD:730953 | 6480464 | Dactinomycin inhibits the reaction [TGFB2 protein results in increased expression of COL1A1 mRNA]; more ... | CTD | PMID:18253093 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:730953 | 6480464 | IFNG protein inhibits the reaction [Tretinoin results in increased expression of TGFB2 mRNA] | CTD | PMID:16007204 |
| all-trans-retinoic acid | increases expression | ISO | RGD:730953 | 6480464 | Tretinoin results in increased expression of TGFB2 mRNA | CTD | PMID:15955085 more ... |
| all-trans-retinoic acid | increases expression | ISO | RGD:730953 | 6480464 | Tretinoin results in increased expression of TGFB2 protein | CTD | PMID:15970678 PMID:15955085 |
| all-trans-retinoic acid | increases secretion | ISO | RGD:730953 | 6480464 | Tretinoin results in increased secretion of TGFB2 protein | CTD | PMID:16473924 PMID:15970678 |
| all-trans-retinoic acid | increases expression | ISO | RGD:730953 | 6480464 | Tretinoin results in increased expression of TGFB2 mRNA | CTD | PMID:17196394 more ... |
| all-trans-retinoic acid | increases expression | ISO | RGD:730953 | 6480464 | Tretinoin results in increased expression of TGFB2 mRNA | CTD | PMID:16007204 more ... |
| all-trans-retinoic acid | affects expression | EXP | | 6480464 | Tretinoin affects the expression of TGFB2 mRNA | CTD | PMID:16235736 |
| all-trans-retinoic acid | increases secretion | ISO | RGD:730953 | 6480464 | Tretinoin results in increased secretion of TGFB2 protein | CTD | PMID:15970678 PMID:16473924 |
| all-trans-retinoic acid | increases expression | ISO | RGD:730953 | 6480464 | Tretinoin results in increased expression of TGFB2 protein | CTD | PMID:15955085 PMID:15970678 |
| all-trans-retinoic acid | increases expression | ISO | RGD:730953 | 6480464 | Tretinoin results in increased expression of TGFB2 mRNA | CTD | PMID:15955085 more ... |
| ammonium chloride | affects expression | ISO | RGD:70491 | 6480464 | Ammonium Chloride affects the expression of TGFB2 mRNA | CTD | PMID:16483693 |
| arsenite(3-) | decreases expression | ISO | RGD:730953 | 6480464 | arsenite results in decreased expression of TGFB2 mRNA | CTD | PMID:16085347 |
| arsenite(3-) | multiple interactions | EXP | | 6480464 | [arsenite co-treated with Benzo(a)pyrene] results in decreased expression of TGFB2 mRNA | CTD | PMID:15894712 |
| arsenite(3-) | decreases expression | EXP | | 6480464 | arsenite results in decreased expression of TGFB2 mRNA | CTD | PMID:15894712 |
| arsenite(3-) | multiple interactions | ISO | RGD:730953 | 6480464 | caffeic acid phenethyl ester inhibits the reaction [arsenite results in decreased expression of TGFB2 mRNA] | CTD | PMID:16085347 |
| astemizole | increases expression | ISO | RGD:70491 | 6480464 | Astemizole results in increased expression of TGFB2 mRNA | CTD | PMID:20221588 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of TGFB2 mRNA | CTD | PMID:15894712 more ... |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of TGFB2 mRNA | CTD | PMID:15034205 more ... |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | AHR protein promotes the reaction [Benzo(a)pyrene results in decreased expression of TGFB2 mRNA] | CTD | PMID:15034205 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of TGFB2 mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of TGFB2 mRNA | CTD | PMID:15894712 more ... |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of TGFB2 mRNA | CTD | PMID:21569818 more ... |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of TGFB2 mRNA | CTD | PMID:15894712 more ... |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of TGFB2 mRNA | CTD | PMID:19770486 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:730953 | 6480464 | Benzo(a)pyrene results in increased expression of TGFB2 mRNA | CTD | PMID:20106945 PMID:19181443 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of TGFB2 mRNA | CTD | PMID:15894712 PMID:21715664 |
| benzo[a]pyrene | affects expression | EXP | | 6480464 | Benzo(a)pyrene affects the expression of TGFB2 mRNA | CTD | PMID:15037607 |
| benzo[a]pyrene | increases expression | ISO | RGD:730953 | 6480464 | Benzo(a)pyrene results in increased expression of TGFB2 mRNA | CTD | PMID:19181443 PMID:20106945 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [arsenite co-treated with Benzo(a)pyrene] results in decreased expression of TGFB2 mRNA | CTD | PMID:15894712 |
| bis(2-chloroethyl) sulfide | decreases expression | EXP | | 6480464 | Mustard Gas results in decreased expression of TGFB2 mRNA | CTD | PMID:18955075 |
| bis(2-ethylhexyl) phthalate | decreases expression | ISO | RGD:70491 | 6480464 | Diethylhexyl Phthalate results in decreased expression of TGFB2 protein; more ... | CTD | PMID:20920545 |
| bisphenol A | decreases expression | ISO | RGD:730953 | 6480464 | bisphenol A results in decreased expression of TGFB2 mRNA | CTD | PMID:16029874 more ... |
| bisphenol A | decreases expression | ISO | RGD:730953 | 6480464 | bisphenol A results in decreased expression of TGFB2 mRNA | CTD | PMID:16029874 more ... |
| bisphenol A | decreases expression | ISO | RGD:730953 | 6480464 | bisphenol A results in decreased expression of TGFB2 mRNA | CTD | PMID:19371625 more ... |
| bisphenol A | decreases expression | ISO | RGD:730953 | 6480464 | bisphenol A results in decreased expression of TGFB2 mRNA | CTD | PMID:19371625 more ... |
| bisphenol A | affects expression | ISO | RGD:730953 | 6480464 | bisphenol A affects the expression of TGFB2 mRNA | CTD | PMID:20170705 |
| bromochloroacetic acid | decreases expression | ISO | RGD:70491 | 6480464 | bromochloroacetic acid results in decreased expression of TGFB2 mRNA | CTD | PMID:16460773 |
| cadmium dichloride | multiple interactions | ISO | RGD:730953 | 6480464 | [sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of TGFB2 mRNA | CTD | PMID:12634122 |
| calciol | increases expression | EXP | | 6480464 | Cholecalciferol results in increased expression of TGFB2 mRNA | CTD | PMID:17170073 |
| calcitriol | increases expression | ISO | RGD:730953 | 6480464 | Calcitriol results in increased expression of TGFB2 mRNA | CTD | PMID:21592394 PMID:16002434 |
| calcitriol | increases expression | ISO | RGD:730953 | 6480464 | Calcitriol results in increased expression of TGFB2 mRNA | CTD | PMID:16002434 PMID:21592394 |
| calcitriol | multiple interactions | ISO | RGD:730953 | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of TGFB2 mRNA | CTD | PMID:21592394 |
| capsaicin | increases expression | ISO | RGD:70491 | 6480464 | Capsaicin results in increased expression of TGFB2 protein | CTD | PMID:22150557 |
| capsaicin | multiple interactions | ISO | RGD:70491 | 6480464 | [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of TGFB2 protein]; more ... | CTD | PMID:22150557 |
| carbamazepine | affects expression | EXP | | 6480464 | Carbamazepine affects the expression of TGFB2 mRNA | CTD | PMID:22634333 |
| carbofuran | increases expression | ISO | RGD:70491 | 6480464 | Carbofuran results in increased expression of TGFB2 mRNA | CTD | PMID:20211217 |
| chloroprene | decreases expression | EXP | | 6480464 | Chloroprene results in decreased expression of TGFB2 mRNA | CTD | PMID:23125180 |
| chlorpyrifos | increases expression | EXP | | 6480464 | Chlorpyrifos results in increased expression of TGFB2 mRNA | CTD | PMID:20350560 |
| cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of TGFB2 mRNA | CTD | PMID:21151649 |
| cocaine | increases expression | ISO | RGD:70491 | 6480464 | Cocaine results in increased expression of TGFB2 mRNA | CTD | PMID:17898221 |
| coumestrol | multiple interactions | ISO | RGD:730953 | 6480464 | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TGFB2 mRNA; more ... | CTD | PMID:19167446 |
| coumestrol | decreases expression | ISO | RGD:730953 | 6480464 | Coumestrol results in decreased expression of TGFB2 mRNA | CTD | PMID:19167446 |
| dasatinib (anhydrous) | increases expression | ISO | RGD:730953 | 6480464 | dasatinib results in increased expression of TGFB2 mRNA | CTD | PMID:20579391 |
| Delta(9)-tetrahydrocannabinol | multiple interactions | EXP | | 6480464 | Tetrahydrocannabinol promotes the reaction [Estradiol results in increased expression of TGFB2 mRNA] | CTD | PMID:8390853 |
| dexamethasone | multiple interactions | ISO | RGD:730953 | 6480464 | [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of TGFB2 mRNA | CTD | PMID:16997883 |
| dexamethasone | decreases expression | ISO | RGD:730953 | 6480464 | Dexamethasone results in decreased expression of TGFB2 mRNA | CTD | PMID:16997883 |
| diazoxide | increases expression | ISO | RGD:70491 | 6480464 | Isoproterenol results in increased expression of TGFB2 mRNA | CTD | PMID:20211217 |
| dibutyl phthalate | increases expression | ISO | RGD:70491 | 6480464 | Dibutyl Phthalate results in increased expression of TGFB2 mRNA | CTD | PMID:21266533 |
| dichromium trioxide | multiple interactions | ISO | RGD:730953 | 6480464 | [sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of TGFB2 mRNA | CTD | PMID:12634122 |
| dioxygen | increases expression | EXP | | 6480464 | Oxygen deficiency results in increased expression of TGFB2 mRNA | CTD | PMID:21531777 |
| dioxygen | multiple interactions | EXP | | 6480464 | rosiglitazone inhibits the reaction [Oxygen deficiency results in increased expression of TGFB2 mRNA] | CTD | PMID:21531777 |
| divanadium pentaoxide | decreases expression | ISO | RGD:730953 | 6480464 | vanadium pentoxide results in decreased expression of TGFB2 mRNA | CTD | PMID:17459161 |
| dobutamine | increases expression | ISO | RGD:70491 | 6480464 | Dobutamine results in increased expression of TGFB2 mRNA | CTD | PMID:16760913 |
| dopamine | increases expression | ISO | RGD:70491 | 6480464 | Dopamine results in increased expression of TGFB2 mRNA | CTD | PMID:16760913 |
| doxorubicin | increases expression | ISO | RGD:70491 | 6480464 | Doxorubicin results in increased expression of TGFB2 mRNA | CTD | PMID:20211217 |
| enalapril | decreases expression | ISO | RGD:70491 | 6480464 | Enalapril results in decreased expression of TGFB2 mRNA | CTD | PMID:17164399 |
| furosemide | increases expression | ISO | RGD:70491 | 6480464 | Furosemide results in increased expression of TGFB2 mRNA | CTD | PMID:16526316 |
| genistein | decreases expression | ISO | RGD:730953 | 6480464 | Genistein results in decreased expression of TGFB2 mRNA | CTD | PMID:16474171 |
| hyaluronic acid | multiple interactions | EXP | | 6480464 | MAP3K3 protein promotes the reaction [TGFB2 protein results in increased abundance of Hyaluronic Acid]; more ... | CTD | PMID:20633555 |
| hyaluronic acid | increases abundance | EXP | | 6480464 | TGFB2 protein results in increased abundance of Hyaluronic Acid | CTD | PMID:20633555 |
| hydrogen peroxide | multiple interactions | ISO | RGD:730953 | 6480464 | [Minocycline co-treated with Hydrogen Peroxide co-treated with TGFB2 protein] results in increased expression of BCL2 mRNA; more ... | CTD | PMID:20606027 |
| indole-3-methanol | multiple interactions | EXP | | 6480464 | Lipopolysaccharides affects the susceptibility to [indole-3-carbinol results in increased expression of TGFB2 mRNA] | CTD | PMID:21948866 |
| indole-3-methanol | increases expression | EXP | | 6480464 | indole-3-carbinol results in increased expression of TGFB2 mRNA | CTD | PMID:21948866 |
| isoprenaline | increases expression | ISO | RGD:70491 | 6480464 | Isoproterenol results in increased expression of TGFB2 mRNA | CTD | PMID:20211217 |
| L-ascorbic acid | increases expression | EXP | | 6480464 | Ascorbic Acid results in increased expression of TGFB2 mRNA | CTD | PMID:15305145 |
| L-cysteine | multiple interactions | ISO | RGD:70491 | 6480464 | Cysteine inhibits the reaction [Thioacetamide results in increased expression of TGFB2 mRNA] | CTD | PMID:15158331 |
| L-methionine | multiple interactions | ISO | RGD:70491 | 6480464 | Methionine inhibits the reaction [Thioacetamide results in increased expression of TGFB2 mRNA] | CTD | PMID:15158331 |
| lead diacetate | multiple interactions | ISO | RGD:730953 | 6480464 | [sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of TGFB2 mRNA | CTD | PMID:12634122 |
| mercury atom | increases expression | ISO | RGD:730953 | 6480464 | Mercury results in increased expression of TGFB2 mRNA | CTD | PMID:16823088 |
| mercury(0) | increases expression | ISO | RGD:730953 | 6480464 | Mercury results in increased expression of TGFB2 mRNA | CTD | PMID:16823088 |
| microcystin-LR | increases expression | EXP | | 6480464 | cyanoginosin LR results in increased expression of TGFB2 mRNA | CTD | PMID:17654400 |
| minocycline | multiple interactions | ISO | RGD:730953 | 6480464 | [Minocycline co-treated with Hydrogen Peroxide co-treated with TGFB2 protein] results in increased expression of BCL2 mRNA; more ... | CTD | PMID:20606027 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | AHR protein inhibits the reaction [Diethylnitrosamine results in increased expression of TGFB2 mRNA] | CTD | PMID:19996281 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of TGFB2 mRNA | CTD | PMID:18282651 PMID:19996281 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of TGFB2 mRNA | CTD | PMID:19996281 PMID:18282651 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | TGFB2 gene mutant form results in increased susceptibility to [Diethylnitrosamine co-treated with Phenobarbital] | CTD | PMID:11526486 |
| N-nitrosodiethylamine | increases response to substance | EXP | | 6480464 | TGFB2 gene mutant form results in increased susceptibility to Diethylnitrosamine | CTD | PMID:11559531 |
| naproxen | multiple interactions | ISO | RGD:70491 | 6480464 | [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of TGFB2 protein]; more ... | CTD | PMID:22150557 |
| ochratoxin A | increases expression | ISO | RGD:70491 | 6480464 | ochratoxin A results in increased expression of TGFB2 mRNA | CTD | PMID:23208426 |
| ochratoxin A | increases expression | ISO | RGD:70491 | 6480464 | ochratoxin A results in increased expression of TGFB2 mRNA | CTD | PMID:23208426 PMID:23358140 |
| paraquat | affects expression | ISO | RGD:70491 | 6480464 | Paraquat affects the expression of TGFB2 mRNA | CTD | PMID:16854511 |
| phenobarbital | multiple interactions | EXP | | 6480464 | TGFB2 gene mutant form results in increased susceptibility to [Diethylnitrosamine co-treated with Phenobarbital] | CTD | PMID:11526486 |
| phenylephrine | increases expression | ISO | RGD:70491 | 6480464 | Phenylephrine results in increased expression of TGFB2 mRNA | CTD | PMID:19443575 |
| phenytoin | decreases expression | EXP | | 6480464 | Phenytoin results in decreased expression of TGFB2 mRNA | CTD | PMID:9118846 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:730953 | 6480464 | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of TGFB2 mRNA | CTD | PMID:16979875 |
| pirinixic acid | multiple interactions | ISO | RGD:730953 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of TGFB2 mRNA | CTD | PMID:19710929 |
| prazosin | multiple interactions | ISO | RGD:70491 | 6480464 | Prazosin inhibits the reaction [Norepinephrine results in increased expression of TGFB2 mRNA] | CTD | PMID:15326086 |
| progesterone | multiple interactions | ISO | RGD:730953 | 6480464 | [Progesterone co-treated with Estradiol] results in decreased expression of TGFB2 mRNA | CTD | PMID:17404688 |
| raloxifene | affects expression | ISO | RGD:730953 | 6480464 | Raloxifene affects the expression of TGFB2 mRNA | CTD | PMID:14699072 |
| raloxifene | multiple interactions | ISO | RGD:730953 | 6480464 | [Raloxifene co-treated with Estradiol] results in increased expression of TGFB2 mRNA | CTD | PMID:21185374 |
| raloxifene | multiple interactions | ISO | RGD:730953 | 6480464 | [Raloxifene co-treated with ESR2 protein] results in increased expression of TGFB2 mRNA | CTD | PMID:19059307 |
| resveratrol | decreases expression | ISO | RGD:730953 | 6480464 | resveratrol results in decreased expression of TGFB2 mRNA | CTD | PMID:19371625 |
| resveratrol | multiple interactions | ISO | RGD:730953 | 6480464 | [Coumestrol co-treated with resveratrol] results in decreased expression of TGFB2 mRNA | CTD | PMID:19167446 |
| resveratrol | increases expression | ISO | RGD:730953 | 6480464 | resveratrol results in increased expression of TGFB2 mRNA | CTD | PMID:12002526 |
| rosiglitazone | decreases expression | EXP | | 6480464 | rosiglitazone results in decreased expression of TGFB2 mRNA | CTD | PMID:21531777 |
| rosiglitazone | multiple interactions | EXP | | 6480464 | rosiglitazone inhibits the reaction [Oxygen deficiency results in increased expression of TGFB2 mRNA] | CTD | PMID:21531777 |
| styrene | affects expression | ISO | RGD:730953 | 6480464 | Styrene affects the expression of TGFB2 protein; more ... | CTD | PMID:16705669 |
| styrene oxide | affects expression | ISO | RGD:730953 | 6480464 | styrene oxide affects the expression of TGFB2 mRNA; more ... | CTD | PMID:16705669 |
| sumatriptan | multiple interactions | ISO | RGD:70491 | 6480464 | [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of TGFB2 protein]; more ... | CTD | PMID:22150557 |
| tamibarotene | increases secretion | ISO | RGD:730953 | 6480464 | Am 80 results in increased secretion of TGFB2 protein; more ... | CTD | PMID:17611697 |
| tamibarotene | increases response to substance | ISO | RGD:730953 | 6480464 | TGFB2 results in increased susceptibility to Am 80; more ... | CTD | PMID:17611697 |
| tamoxifen | affects expression | ISO | RGD:730953 | 6480464 | Tamoxifen affects the expression of TGFB2 mRNA | CTD | PMID:14699072 |
| tamoxifen | multiple interactions | ISO | RGD:730953 | 6480464 | [Tamoxifen co-treated with ESR2 protein] results in increased expression of TGFB2 mRNA | CTD | PMID:19059307 |
| testosterone | multiple interactions | ISO | RGD:730953 | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of TGFB2 mRNA | CTD | PMID:21592394 |
| testosterone | increases expression | ISO | RGD:730953 | 6480464 | Testosterone results in increased expression of TGFB2 mRNA | CTD | PMID:21592394 |
| tetrachloromethane | affects expression | EXP | | 6480464 | Carbon Tetrachloride affects the expression of TGFB2 mRNA | CTD | PMID:17484886 |
| tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of TGFB2 mRNA | CTD | PMID:15056808 |
| tetrachloromethane | increases expression | ISO | RGD:70491 | 6480464 | Carbon Tetrachloride results in increased expression of TGFB2 mRNA | CTD | PMID:16644059 |
| thioacetamide | multiple interactions | ISO | RGD:70491 | 6480464 | Cysteine inhibits the reaction [Thioacetamide results in increased expression of TGFB2 mRNA]; more ... | CTD | PMID:15158331 |
| thioacetamide | increases expression | ISO | RGD:70491 | 6480464 | Thioacetamide results in increased expression of TGFB2 mRNA | CTD | PMID:15158331 PMID:17292413 |
| thioacetamide | increases expression | ISO | RGD:70491 | 6480464 | Thioacetamide results in increased expression of TGFB2 mRNA | CTD | PMID:17292413 PMID:15158331 |
| trans-resveratrol | decreases expression | ISO | RGD:730953 | 6480464 | resveratrol results in decreased expression of TGFB2 mRNA | CTD | PMID:19371625 |
| trans-resveratrol | multiple interactions | ISO | RGD:730953 | 6480464 | [Coumestrol co-treated with resveratrol] results in decreased expression of TGFB2 mRNA | CTD | PMID:19167446 |
| trans-resveratrol | increases expression | ISO | RGD:730953 | 6480464 | resveratrol results in increased expression of TGFB2 mRNA | CTD | PMID:12002526 |
| trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of TGFB2 mRNA | CTD | PMID:15363585 |
| troglitazone | multiple interactions | ISO | RGD:730953 | 6480464 | troglitazone inhibits the reaction [TGFB2 protein results in increased expression of COL1A1 mRNA]; more ... | CTD | PMID:18253093 |
| troglitazone | increases expression | ISO | RGD:70491 | 6480464 | troglitazone results in increased expression of TGFB2 mRNA | CTD | PMID:21515302 |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of TGFB2 mRNA | CTD | PMID:17569031 |
| troglitazone | decreases response to substance | ISO | RGD:730953 | 6480464 | troglitazone results in decreased susceptibility to TGFB2 protein | CTD | PMID:18253093 |
| urethane | multiple interactions | EXP | | 6480464 | Freund's Adjuvant inhibits the reaction [Urethane results in decreased expression of TGFB2 mRNA]; more ... | CTD | PMID:12810352 |
| urethane | decreases expression | EXP | | 6480464 | Urethane results in decreased expression of TGFB2 mRNA | CTD | PMID:12810352 |
| zinc atom | multiple interactions | ISO | RGD:730953 | 6480464 | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of TGFB2 mRNA | CTD | PMID:16979875 |
| zinc(0) | multiple interactions | ISO | RGD:730953 | 6480464 | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of TGFB2 mRNA | CTD | PMID:16979875 |